Colleen received her BS in Biological Engineering from MIT in 2019. Following graduation, she worked at Obsidian Therapeutics as a Research Associate for two years, developing an engineered TIL therapy for melanoma that is currently in clinical trials. She joined the Pritzker School for Molecular Engineering as a graduate student in 2021, where she studies mechanisms of cancer immunotherapy potentiation in lymphangiogenic melanoma. Outside of lab, she is involved in science outreach through PME and volunteers for Big Brothers Big Sisters of America. She enjoys running and walking the lakefront and spending time with her two cats.